Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Maybe it would speed up process if they got some grants ?
Amazing! Matt said he’s getting great results and others even more so: https://www.facebook.com/6209609/posts/10107776558920443?sfns=rmo
I guess you’re not one of the winners because you keep looking back and posting negative messages. LOL!! Is it to make you feel better for it to go down to lower price than what you sold it at? Me, I’m letting my 3M+ shares ride to at least $.10 before I think of taking some off the table.
Let’s all pick up an extra thousand or 2 and help contribute to the buying panic.
Too many indications this one is going much higher and to be valued shortly at $1B and eventually $6B, $300/share, IMO:
- Received $16M no strings attached, non-diluted grant to fund Phase 3. No organization is going to give that kind of money unless they are super confident it will pass phase 3.
- The call today with so many ALS patients and family members who have researched and some who took part in Phase 2 or Phase 3 that were pleading to continue treatment. That shows the results they're getting or have heard others getting.
- The 6 Phase 3 locations are the best well known facilities in the US, ie: MA General, Mayo Clinic, etc. One of patients said today they knew John Hopkins/MD was vying to accepted as one of the centers.
- They have seen positive results in lab for MS, Parkinson and Alzheimer.
The only thing holding them back is $'s to move quicker which is why it would make sense for large deep pocket Pharma/Bio company to eventually purchase them. DYAX was bought for $6 billion for late-stage experimental treatment they were working on for a rare dangerous inflammatory disease that can block breathing. Once we get closer to Phase 3 approval, the stock should be trading with market cap from $1B - $6B IMO.
Agreed, $BCLI is on a mission and its great to be shareholder of company that will be treating so many in need. I will have to listen to call again but CEO mentioned today funding is not only to help with the ALS Phase 3 which was already fully funded with the California $15 Million non-diluted grant but to expand into other areas, ie: MS, Parkinsons, Alzheimers. This is huge!!!
you can find article on disbarred lawyer by google search his name (they left off peter on thier PR) and town. Insiders have been selling which also gives indication on this one. https://www.insidearbitrage.com/insider-transactions/?searchfieldm=MYHI%3A+Mountain+High+Acquisitions+Corp.&desk=no&Search=Search&search_type=Symbol
That was back in April I sold, i did sell my remaining 10,000 shares today before close on run up. I would be careful with this one, very shady company IMO, the consultant they hired in Jan is reportedly a disbarred lawyer who was charged with scamming elderly women out of money to pay his back taxes.
CEO mentions possible JV but hints no buy out in near time which is fine by me, let it ride to $30 first
RTT had strong bipartisan support, it would have been signed regardless of POTUS, IMO.
Agreed. I don't know how a company offering a treatment for ALS showing positive results and potential to treat MS, Parkinson and Alzheimers doesn't have a $1 billion market cap by now, $50/share as starters. Eventually a $6 billion+ company- $300 PPS. IMO. Look at DYAX buyout by Shire for $6 billion and they were treating hereditary angioedema – a rare blood disorder. Isn't ALS, MS and Parkinsons much more prevalent than hereditary angioedema?
The clinical trial results and medical community will be more than enough to push this stock higher. I’m curious when they will start the pivot to MS, Parkinsons and Alzheimer’s. I don’t care if I need to wait for a year as long as they are executing, this is easy 10 bagger with ALS results and will be 60 bagger if they start getting success with MS, Parkinsons and Alzheimer’s. $300+ PPS, IMO.
Game changing technology applicable to multiple verticals, Education: click here for assignment, click here to download reference material, click here to provide feedback on areas you need help.
Medical- Click here for sample video for PT exercises, click here for guidance on your medication, click here to schedule follow up apppointment.
Real Estate, see the click heres, here: https://nfusz.com/super/ajax/ajax2.php?mediaid=iWd0dm
All powered by NFusz. Everyone seeing software demo are in awe and early adopters, rest will follow or be left behind. same with investors, people buying in now for pennies before any revenues showing up, a year from now quite a different story. Tens of millions in revenues a year from now, IMO.
RTT will be applicable to MS, Parkinson and Alzheimer which are next in funnel for NurOwn with safety and results proven in BCLI trials. See slides 6-8 on presentation: https://t.co/okNMoNcGgs $BCLI is $30 to $300 PPS coming soon! IMO.
Aetna (legacy US Healthcare) has large presence in Blue Bell, PA.
It’s called speculation which is investing. Communication with patients is great use case of FUSZ technology.
Two potential notifyHealth partners based in PA:
https://www.amerisourcebergen.com/abcnew/
https://www.uhsinc.com/
Added to my position today at $.58. Company has impact product that has many use cases. They're making strong partnerships to expand its reach. It's a matter of time before revenues show up and will be in tens of millions by 1st Qtr 2019. IMO
What do you consider minimum for “huge” position? 20K, 40K, 100K, 200K shares?
Phase 3 in progress, as well as investor relations push that should bring awareness to investment opportunity. Positive results from Phase 2 trial with only 1 dose, patients will be getting 3 doses in Phase 3 trial. Company received $16M grant after phase 2 trial which is good indication of positive expectations.
Link to company’s pipeline:
http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9Njg5ODUxfENoaWxkSUQ9NDAwMjY0fFR5cGU9MQ==&t=1
Load up at open, Load up if it dips, Load up if it rises. 6-12 months this is crazy big. A huge business could be built on their NotifyID feature alone and it’s rarely talked about. IMO
Thanks, they should try to clean up the website to make it more user friendly via mobile and also to accept credit card payment. website seems to work well through desktop browser but still need to get CC option.
What’s best way to order Zoe CBD? Website seems cumbersome.
Dead Cat bounce next week and then continuing upward trend as more people become exposed to nFUSZ software and see its use cases. Very powerful B-C marketing tool, many people will want in. NotifyID is the bomb, you'll start to see show up in many people's signatures. A business could be built on that feature alone, IMO.
Agreed.
WOW! If that doesn't get you fired up your wood must be wet!
Yes, I worked for Frontier Communications in the 1990's and our CEO Joseph Clayton had a saying, "FRO-50. Our symbol was FRO and stock price was in low 20's, his thought we should be at least 50+. He was very respected CEO in a very regulated industry. It was a driving force for everyone in the company and I'm sure our shareholders appreciated it too.
Don’t worry about a day or 2 or week or 2; think several months out. More and more people being exposed to nFusz the products, technology, the use cases, management team, etc. Have to believe all the folks at the show seeing it first hand have to be thinking “how do I get a piece of this”. We’re not going to be at $2 very long, yes it will go up and down but we’re still very low on upward curve and it going to grow very fast but very fast is still months and at least a year or two. Not a day, or a week or month.. Everyone who’s done thier DD should be loading up at these dips. I am.
3rd Party endorsement, “HOT! HOT! HOT!” Great timing right before Oracle show.
I just got my first look at V2.0 @nFuszInc Beautiful! This one is HOT! HOT! HOT! My comprehensive review should be out real soon now. Stay tuned! #CRM
— Rich Bohn (@RichBohn) April 20, 2018
Real company with new and energized management in hot market, this one is going to be nice ride.
See following link!!! All the large enterprise CRM users will see this review and move quickly to adopt to stay ahead of the competition. Do you guys know what we're sitting on here? This is becoming self-evident. shorts and penny flippers left in the dust:
I just got my first look at V2.0 @nFuszInc Beautiful! This one is HOT! HOT! HOT! My comprehensive review should be out real soon now. Stay tuned! #CRM
— Rich Bohn (@RichBohn) April 20, 2018
Yes!!! 4,000 more shares bought at $2.53. Anything less than $3 is a gift!!
Rich Bohn will be writing review on FUSZ and by his tweet it looks like it won't be half bad, LOL. All large enterprise CRM users will take note! Go FUSZ!!!!
https://twitter.com/hashtag/CRM?src=hash
from claytrader: "Big picture stair step in the upward direction" Go Fusz!
https://claytrader.com/stock_chart/FUSZ/?utm_source=social&utm_medium=twitter&utm_campaign=chart
I sold 90,000 shares of My MYHI this AM at $.09, keeping 10,000 to see if they get their act together. I saw in their Jan press release they hired consultant who after a little research I find out is a disbarred lawyer accused of scamming elderly person of money to help pay his real estate back taxes. Birds of a feather flock together. This one smells.
http://www.mountainhighac.com/press_releases.html
https://www.mywsba.org/DisciplineNotice/DisciplineDetail.aspx?dID=1648
When do we expect 1Q results to be released? we're going to need to see company executing on its plans and existing assets by showing revenue. No revenue and this one could go belly up soon.
FYI, I've owned this one about 9 years, this is first year Ive added to my original position. i plan to keep accumulating this year as i sell other holdings.
this should be breakout year for BCLI, phase 3 can always get accelerated by results and the fact they received $16 million grant last year to help fund phase 3 is indication independent 3rd parties expect patients to improve. patience for this one, whether its this year or next year, this could be a $3 to $30 overnight.
SF.com , they have largest % of market.